Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial.
Cuzick J, Sestak I, Forbes JF, Dowsett M, Cawthorn S, Mansel RE, Loibl S, Bonanni B, Evans DG, Howell A; IBIS-II investigators.
Lancet. 2020 Jan 11;395(10218):117-122. doi: 10.1016/S0140-6736(19)32955-1. Epub 2019 Dec 12.
Merkel cell carcinoma, melanoma, metastatic mimics of breast cancer.
Troxell ML.
Semin Diagn Pathol. 2017 Sep;34(5):479-495. doi: 10.1053/j.semdp.2017.05.009. Epub 2017 May 31.
In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers.
Bosserhoff AK, Moser M, Hein R, Landthaler M, Buettner R.
J Pathol. 1999 Mar;187(4):446-54. doi: 10.1002/(SICI)1096-9896(199903)187:4<446::AID-PATH267>3.0.CO;2-Y.
In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
Oba T, Makino K, Kajihara R, Yokoi T, Araki R, Abe M, Minderman H, Chang AE, Odunsi K, Ito F.
J Immunother Cancer. 2021 May;9(5):e002432. doi: 10.1136/jitc-2021-002432.
Paget's disease of the breast.
Marques-Costa JC, Cuzzi T, Carneiro S, Parish LC, Ramos-e-Silva M.
Skinmed. 2012 May-Jun;10(3):160-5; quiz 165.
Metastatic nonhematopoietic neoplasms to the breast: a study of 238 cases.
Zhou P, Chang N, Abraham SC, Albarracin CT, Huo L, Chen H, Ding Q, Resetkova E, Middleton LP, Sahin AA, Bu H, Wu Y.
Hum Pathol. 2022 Jul;125:59-67. doi: 10.1016/j.humpath.2022.04.009. Epub 2022 Apr 18.
Quality assessment of a large primary GP skin cancer service in Auckland, New Zealand.
Wen D, Gale K, Martin R.
N Z Med J. 2020 Feb 7;133(1509):17-27.
Incidence of In Situ and Invasive Melanoma in Denmark From 1985 Through 2012: A National Database Study of 24,059 Melanoma Cases.
Helvind NM, Hölmich LR, Smith S, Glud M, Andersen KK, Dalton SO, Drzewiecki KT.
JAMA Dermatol. 2015 Oct;151(10):1087-95. doi: 10.1001/jamadermatol.2015.1481.
Cancer risk in patients with earlier diagnosis of cutaneous melanoma in situ.
Wassberg C, Thörn M, Yuen J, Hakulinen T, Ringborg U.
Int J Cancer. 1999 Oct 29;83(3):314-7. doi: 10.1002/(sici)1097-0215(19991029)83:3<314::aid-ijc5>3.0.co;2-9.
Immunohistological analysis of P53 expression in human skin tumors.
Urano Y, Oura H, Sakaki A, Nagae H, Matsumoto K, Fukuhara K, Nagae T, Arase S, Ninomiya Y, Nakanishi H, et al.
J Dermatol Sci. 1992 Sep;4(2):69-75. doi: 10.1016/0923-1811(92)90061-f.
